MARK RIVELLESE, M.D.
Ophthalmology Physician · ATLANTA, GA
Individual Active NPI 1891798039
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 931 | 48,769 | $10,363,619 | $3,065,950 | $2,403,792 |
| 2023 | 883 | 29,056 | $9,794,571 | $2,811,155 | $2,203,093 |
| 2022 | 914 | 12,426 | $9,980,445 | $2,913,186 | $2,285,180 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J2777 | Injection, faricimab-svoa, 0.1 mg | 40,080 | $35 | $27 |
| 92134 | Imaging of retina | 2,127 | $40 | $31 |
| 67028 | Injection of drug into eye | 1,293 | $124 | $98 |
| 92014 | Established patient complete exam of visual system | 1,094 | $126 | $89 |
| J0178 | Injection, aflibercept, 1 mg | 948 | $824 | $649 |
| J2782 | Injection, avacincaptad pegol, 0.1 mg | 800 | $108 | $86 |
| J2778 | Injection, ranibizumab, 0.1 mg | 585 | $163 | $124 |
| J0177 | Injection, aflibercept hd, 1 mg | 480 | $330 | $263 |
| J7312 | Injection, dexamethasone, intravitreal implant, 0.1 mg | 203 | $202 | $156 |
| 92012 | Established patient problem focused exam of visual system | 144 | $89 | $63 |
| 92250 | Photography of the retina | 135 | $36 | $28 |
| J9035 | Injection, bevacizumab, 10 mg | 128 | $70 | $51 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Ophthalmology Physician | 207W00000X | ✓ | 050911 | GA |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Ophthalmology Physician providers in Georgia
- NPI 1023888252
- NPI 1740267806
- NPI 1700840147
- NPI 1275039638
- NPI 1134412877
- NPI 1902913429
- NPI 1558637512
- NPI 1821052077
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.